Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prev close 5.26 · gapped below the open, then crossed back over prior close. High/low 5.27 at 10:15 am ET, 5.20 at 11:00 am ET.
Savara Inc has 7 disclosed suppliers and 0 disclosed customers. Each one is named in an SEC filing, either Savara Inc’s own annual report or the counterparty’s, and carries the sentence that discloses it.
No filing we have read names a customer of Savara Inc. Customers appear here when Savara Inc names them, or when a company names Savara Inc as a supplier in its own annual report.
Savara Inc
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“In February 2024, we entered into a Master Services Agreement with FUJIFILM Diosynth Biotechnologies ("Fujifilm") to complete a technology transfer of the drug substance manufacturing process from GEMA Biotech S.A. ("GEMA") and to manufacture commercial supply of MOLBREEVI.”
FILING10-K0001193125-26-105076cik 0001160308
“In April 2019, we entered into a manufacture and supply agreement with GEMA, which was amended on December 7, 2022 and December 13, 2023 (the "GEMA Agreement"), pursuant to which GEMA may supply the active pharmaceutical ingredient ("API") for MOLBREEVI exclusively to us for commercial sale and continue to supply the API to us for clinical trials and research and development activities.”
FILING10-K0001193125-26-105076cik 0001160308
“We entered into a master services agreement ("Parexel MSA") with Parexel on March 5, 2021, pursuant to which Parexel provides contract research services related to our clinical trials.”
FILING10-K0001193125-26-105076cik 0001160308
“For the supply of our exclusive, proprietary eFlow ® nebulizer system that is part of the MOLBREEVI drug-device combination, we have a long-term supply agreement in place with PARI.”
FILING10-K0001193125-26-105076cik 0001160308
“We have entered into an agreement and related work orders with Patheon under which Patheon manufactures our MOLBREEVI product candidate for clinical trials.”
FILING10-K0001193125-26-105076cik 0001160308
“We entered into a master services agreement with Selvita on January 17, 2024 (the "Selvita MSA") under which Selvita performs batch control testing and analyses of our MOLBREEVI drug product and drug substance through certain cell-based bioassays.”
FILING10-K0001193125-26-105076cik 0001160308
“We partnered with TrilliumBiO, a modern health solutions provider and a Clinical Laboratory Improvement Amendments ("CLIA")-certified lab, to develop the test.”
FILING10-K0001193125-26-105076cik 0001160308
Watchlist prices, news filtered to it, and its next report on your desk.
SVRA (Savara Inc) has 7 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.